james hebrew
@jameshebrewjames hebrew
I have been on the internet lately, looking for something to read and that is how I came across your site and saw this article of yours. So, I decided to see what it says and I find out that it is so amazing. You really did great work on your site... moreI have been on the internet lately, looking for something to read and that is how I came across your site and saw this article of yours. So, I decided to see what it says and I find out that it is so amazing. You really did great work on your site and the articles you posted on it. You really take your time in writing this article and they are clearly detailed
as the articles on the site <a href="www.rootsanalysis.com">rootsanalysis</a>. Please check the report <a href="https://www.rootsanalysis.com/reports/protein-design-and-engineering-market.html">Protein design</a> less
Updates
Info
Personal Information
- First Name james
- Last Name hebrew
- Gender Male
Albums
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Posts
-
Posted in the topic Digital Biomanufacturing market Analysis and Trends by 2022-2035 in the forum TechnologyMay 24, 2023 2:50 AM EDT
The “Digital Biomanufacturing Market, 2023-2035” report features an extensive study of various type of technologies, such as PAT, DAS, MES and digital twins offered by digital biomanufacturing providers.
Key Inclusions
- A general introduction to digital biomanufacturing, featuring a detailed discussion on various types of technologies that support digital bioprocessing. In addition, it presents the key challenges and future perspectives associated with the employment of digital technologies in the field of biomanufacturing.
- A detailed assessment of the overall market landscape of companies offering digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company (CDMO provider and software provider), number of platforms offered, deployment options (cloud based, on-premises, corporate datacenter and hybrid), platform capabilities (process automation, bioprocess optimization and controls, process connectivity, scalability, data integration, process monitoring and visualization, performance analysis, report generation and documentation, smart manufacturing, document control, production tracking, performance analysis and data integration), software capabilities (process intelligence, data integration, real-time process monitoring, data visualization, performance analysis and control prediction, reporting and data management), type(s) of biologic(s) manufactured, other compatible platforms (artificial intelligence / machine learning / cloud based, big data, internet of things, augmented reality and virtual reality) and type of end user(s) (industry and non-industry), integrating software (enterprise resource planning (ERP), manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered (training, implementation / upgradation and general support), area(s) of application (asset / process management, clinical trials, personalized treatment, medical training, surgical planning, health monitoring and diagnosis).
- A detailed competitiveness analysis of digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on supplier strength (in terms of years of experience and company size), technology portfolio (considering deployment options, number of platform capabilities, type of end user(s), software capabilities, area(s) of application, type(s) of twin(s)) and type(s) of biologic(s) manufactured.
- Elaborate profiles of key players (companies offering more than one platform and established before 2012) engaged in the digital biomanufacturing domain, which are actively providing software based on PAT, DAS, MES and digital twins. Each profile includes a brief overview of the company, along with information on capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.
- A benchmark analysis highlighting the capabilities of companies (in terms of their expertise across various platforms related to the manufacturing of biologics) engaged in this domain, across key peer groups.
- An analysis featuring information on recent partnerships inked between stakeholders engaged in this domain, based on several relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity, during the period 2018-2022.
- A detailed analysis highlighting the market concentration of key industry stakeholders (companies offering more than one platform) across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.
- A detailed industry lifecycle analysis that indicates various stages, including emergence, growth, maturation and eventual decline for the digital biomanufacturing industry. The primary purpose of this analysis is to develop a better understanding of the current position / phase of the industry on the lifecycle chart (based on historical trends, partnership activity and various investments made by players engaged in this domain) and predict the upcoming events that are likely to drive the growth of this domain. Further, it presents short-term and long-term impacts of various key parameters that are expected to highly impact the wider adoption of digitalization in the field of biomanufacturing.
.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
- Type of Technology
- Process Analytical Technology (PAT)
- Data Analysis Software (DAS)
- Manufacturing Execution Systems (MES)
- Digital Twins
- Deployment Options
- Cloud-based Deployment Options
- On-premises Deployment Options
- Type(s) of Biologic(s) Manufactured
- Antibodies
- Cell and Gene Therapies
- Proteins
- Vaccines
- Others
- Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North America
Key Questions Answered
- What is the global market size of digital biomanufacturing?
- Which are the top players in the global digital biomanufacturing market?
- What are the factors driving the digital biomanufacturing market?
- Which region has the highest market share in the global digital biomanufacturing market?
- What are the leading market segments in digital biomanufacturing market?
- Which segment, in terms of deployment options, accounts for the largest share in the global digital biomanufacturing market?
- What are the partnership and collaboration trends in the digital biomanufacturing domain?
- What is the growth rate (CAGR) in the global digital biomanufacturing market?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #bioprocesssimulationsoftware #bioprocessing4.0
-
Posted in the topic Cell and gene therapy CRO market in the forum TechnologyMay 19, 2023 5:34 AM EDT
Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
- A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
- A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
- Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
- A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
- An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
- A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
- A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
- A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Area of Expertise
- Cell Therapy
- Gene Therapy
- Scale of Operation
- Preclinical
- Clinical
- Drug Discovery
- Therapeutic Area
- Oncological Disorders
- Neurological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune Disorders
- Blood Disorders
- Rare / Genetic Disorders
- Ophthalmic Disorders
- Other disorders
- Analysis by Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
Key companies covered in the report
- Altasciences
- Charles River Laboratories
- Creative Biolabs
- IQVIA
- Medpace
- PPD
- Precision for Medicine
- Accelera
- Evotec
- ICON
- Syneos Health
- CMIC Group
- Labcorp
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
You may also be interested in the following titles:
Cell Therapy Manufacturing Market
You may also like to learn what our experts are sharing in Roots educational series:
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com#CellandgenetherapyCROMarket #CellandgenetherapyCROMarketGrowth #Geneandcelltherapy #cellandgenetherapycro #cellandgenetherapies
-
Posted in the topic Bacteriophage therapeutics market 2022 – Industry Growth by 2035 in the forum TechnologyMay 15, 2023 3:35 AM EDT
With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophagetherapeutics market has been analyzed across the following segments:
- Type of Therapeutic Area
- Infectious Diseases
- Oncological Disorders
- Other Disorders
- Distribution by Route of Administration
- Oral Route
- Rectal Route
- Intravesical Route
- Topical Route
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
- Adaptive Phage Therapeutics
- ContaFect
- Eliava BioPreparations
- Micreos
- NPO Microgen
- Phagelux
- Pherecydes Pharma
Table of Content
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
- COMPANY AND DRUG PROFILES
- CLINICAL TRIAL ANALYSIS
- PATENT ANALYSIS
- PUBLICATION BENCHMARKING ANALYSIS
- ACADEMIC GRANTS ANALYSIS
- FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
- START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
- CONCLUSION
- EXECUTIVE INSIGHTS
- APPENDIX I: TABULATED DATA
- APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
You may also like to learn what our experts are sharing in Roots educational series:
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Monkeypox: Disease Overview, Transmission and Diagnosis
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#Bacteriophagetherapeuticsmarket #Bacteriophagetherapeuticsmarketsize #bacteriophage #phage# bacteriophagetherapy
-
Posted in the topic TIL Therapies market Growth Analysis by 2035 in the forum TechnologyMay 12, 2023 2:17 AM EDT
The “Global TIL-based Therapy Market (2nd Edition), 2023-2035”report features an extensive study of the current market landscape and future potential of TIL-based therapies over the next decade.
Key Inclusions
- An executive summary of the insights captured during our research. It offers a high-level view on the current state of globalTIL therapies market and its likely evolution in the mid-long term.
- A general overview of TIL-based therapies in comparison to conventional forms of therapy that are being used for the treatment of various oncological indications. Further, it includes historical evolution of cancer immunotherapy, general manufacturing procedure of T-cell immunotherapies, and key attributes in the development of TIL-based therapies.
- A detailed assessment of the overall market landscape of TIL-based therapies, based on several relevant parameters, such as type of developer (industry and non-industry), phase of development (preclinical, phase I, phase I/II, phase II, phase III and approved), therapeutic area (hematological cancer, solid tumor and others), target indication (melanoma, ovarian cancer, cervical cancer, lung cancer, pancreatic cancer, sarcoma, breast cancer, squamous cell carcinoma, fallopian tube cancer, gastric cancer, head and neck squamous cell carcinoma and others), source of T-cells (autologous and allogeneic), route of administration (intravenous and hepatic arterial infusion), dosing frequency (single dose and multiple dose), target patient segment (children, adults and seniors), and type of therapy (monotherapy and combination therapy). Further, the chapter also provides developer landscape of industry and non-industry players engaged in this domain.
- An analysis of completed, ongoing, and planned clinical studies related to TIL-based therapies, based on several relevant parameters, such as trial registration year, enrolled patient population, trial status, trial phase, target patient segment, type of sponsor / collaborator, study design, most active players (in terms of number of registered trials), key focus areas and geography.
- An insightful analysis highlighting the key opinion leaders (KOLs) in this domain, featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies, considering them to be KOLs, who are actively involved in R&D of TIL-based therapies. In addition, it compares the relative expertise of KOLs based on a proprietary scoring criterion with that of a third party.
- Elaborate profiles of mid- to late-stage clinical products (phase I/II or above); each profile features an overview of the therapy, its mechanism of action, dosage information, details on the cost and sales information (wherever available), a clinical development plan, and clinical trial results.
- A detailed analysis of recent partnerships inked between several stakeholders engaged in this domain, covering R&D agreements, license agreements (specific to technology platforms and product candidates), manufacturing agreements, clinical trial collaborations and others.
- An analysis of the funding and investments that have been made into companies having proprietary TIL-based products / technologies, including venture capital financing, capital raised from Initial Public Offerings (IPOs) and subsequent offerings, grants, and debt financing.
- An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022, based on several relevant parameters, such as type of patent (granted and patent applications), patent publication year, geographical distribution, type of player, Cooperative Patent Classification (CPC) symbols, emerging focus areas, leading players (in terms of number of patents), and patent benchmarking. In addition, it features a patent valuation analysis, which evaluates the qualitative and quantitative aspects of the patents.
- A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.
- An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies. It features different models / approaches that a pharmaceutical company may choose to adopt to decide the price of a TIL-based therapy that is likely to be marketed in the coming years.
- Elaborate profiles of the leading players in the domain of TIL-based therapies. Each company profile includes an overview of the developer and a brief description of the product portfolio specific to TIL-based therapies, the technology portfolio (if available), recent developments related to TIL-based therapies, and the manufacturing capabilities of the companies. Additionally, we have provided details of the strategic / venture capital investments made in these companies.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
- Target Indication(s)
- Cellectis
- Cellular Biomedicine Group
- Iovance Biotherapeutics
- Lytix Biopharma
- Phio Pharmaceuticals
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
Key Questions Answered
- What is the growth rate of TIL-based therapy market?
- Which region has the highest growth rate in the TIL-based Therapies market?
- How many players are developing TIL-based Therapies?
- Which target indication covers the largest TIL-based therapy market share?
- What is the partnership and collaboration trend in the TIL-based therapy domain?
- What is the current IP landscape of TIL-based therapies market?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
You may also be interested in the following titles:
Medical Device Coatings and Surface Modification Technologies Market
mRNA Synthesis and Manufacturing Services Market
You may also like to learn what our experts are sharing in Roots educational series:
Applications of Blockchain in Various Sectors: An Introduction
Intracellular Drug Delivery – Future Potential
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#TILTherapiesMarketSize #TILTherapiesMarketGrowth #TILimmunotherapies #TILbasedproducts #TILMarket
-
Posted in the topic non-viral drug delivery system market in the forum TechnologyMay 9, 2023 6:50 AM EDT
The new market report titled ‘Non-Viral Drug Delivery Systems Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Non-Viral Drug Delivery Systems Market.
The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The Non-Viral Drug Delivery Systems Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet.
Non-Viral Drug Delivery Systems Market Characterization:
Market Scope and Market Size:
The Non-Viral Drug Delivery Systems market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Non-Viral Drug Delivery Systems market in terms of market size & volume and significant information pertaining to product bifurcation and application overview.
Key Market Contenders:
This particular section of the report covers all the necessary details of the renowned market players operating in the Non-Viral Drug Delivery Systems market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market.
The section of this report focusing on the competitive terrain of the Intracellular Drug DeliverySystems market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period.
Main chapters covered in this report:
Part 01: Market Overview
Part 02: Market Size, by regions
Part 03: Market Revenue, by countries
Part 04: Market Competition, by key players
Part 05: Company Profiles
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities
Digital Therapies: The “Digital Pills” of current generation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
#nonviraldrugdeliverysystemmarket #nonviraldrugdeliverysystemmarketSize #genedeliverysystems #intracellulardelivery #intracellular #drugdelivery
